Reports show there is not enough evidence to determine whether multivitamins can reduce your risk of disease or cancer. CNBC's Seema Mody reports how this new finding may impact the industry.» Read More
If strong sales have piqued your interest in retailers, trade the space like this.
How is the global growth story going to be resolved? We're again near new highs, but so far in March it's the defensive names that have advanced, like Coca-Cola and Procter & Gamble. The market leaders earlier in the year were largely global commodity and industrial companies such as Caterpillar, but now those names have either moved sideways or declined in March over concerns on global growth.
Take a look at some of Tuesday morning’s early movers:
When GNC hit the market in April, it had its fair share of critics. But GNC has emerged as the top IPO in a year where six percent less money was raised than 2010, according to the Wall Street Journal.
Although tech and energy make up 57 percent of the deals this year, the most successful IPO, based on price appreciation, is GNC, a nutritional-product retailer that went public back in April for $16 a share and is up nearly 75 percent since then.
Get Cramer's calls on ON Semiconductor, GNC, BP Prudhoe Bay Royalty Trust and more.
Just a decade ago, sports drink consumers pretty much had one Gatorade option — full calorie Gatorade. Brand managers at the time reasoned that the formula for the masses didn't need to be changed. The Gatorade formula designed by four University of Florida doctors in 1965 was still perfect athletes of all shapes and sizes. But the business quickly changed.
Stocks target highs with jobs on the horizon, Irish banks quake in their boots, GNC faces the market—and what's happening in Omaha? Here's what we're watching …
Here's what you should be watching Thursday, March 30.